According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,14 โฌ. In 2022 the company made an earnings per share (EPS) of -1,21 โฌ a decrease over its 2021 EPS that were of -0,94 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -1,16 โฌ | -4.51% |
2022 | -1,21 โฌ | 29.13% |
2021 | -0,94 โฌ | -4.63% |
2020 | -0,99 โฌ | 10.2% |
2019 | -0,89 โฌ | 0% |
2018 | -0,89 โฌ | 25.64% |
2017 | -0,71 โฌ | 4% |
2016 | -0,68 โฌ | 27.12% |
2015 | -0,54 โฌ | -13.24% |
2014 | -0,62 โฌ | 23.64% |
2013 | -0,50 โฌ | -30.38% |
2012 | -0,72 โฌ | -37.3% |
2011 | -1,15 โฌ | 65.79% |
2010 | -0,69 โฌ | 117.14% |
2009 | -0,32 โฌ | -46.15% |
2008 | -0,59 โฌ | -26.97% |
2007 | -0,81 โฌ | -40.67% |
2006 | -1,37 โฌ | 48.51% |
2005 | -0,92 โฌ | 1% |
2004 | -0,91 โฌ | 38.89% |
2003 | -0,66 โฌ | -25% |
2002 | -0,88 โฌ | 231.03% |
2001 | -0,26 โฌ | -56.72% |
2000 | -0,61 โฌ | 107.22% |
1999 | -0,29 โฌ | 2.94% |
1998 | -0,29 โฌ | -55.84% |
1997 | -0,65 โฌ | 11.59% |
1996 | -0,58 โฌ |